Overview

Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting Conditions

Status:
Completed

Trial end date:
2020-12-21

Target enrollment:

Participant gender:

Summary

Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare two tablets of Ivermectin tablets (3 mg Ivermectin) versus two tablets of Stromectol ® tablets (3 mg Ivermectin), in healthy subjects under fasting conditions.

Phase:

Phase 1

Details

Lead Sponsor:

Pharmactive Ilac Sanayi ve Tic A.S.

Treatments:

Ivermectin